Kimberly Manhard, Executive VP, Drug Development at HERON THERAPEUTICS, INC. /DE/ (HRTX), sold 43,084 shares at $15.33 ($661K) on 2017-04-24, disclosed to the SEC on 2017-04-24.
Open-market sale of $661k HRTX by Executive VP, Drug Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.33 | 21,542 | $330K | 50.0% |
| 2 | $15.33 | 21,542 | $330K | 50.0% |
| Total | $15.33 avg | 43,084 | $661K | 100% |
| Filing → |
| INBX | BUY | 2024-08-30 | $140K | — | Filing → |
| HRTX | SELL | 2022-05-04 | $7K | — | Filing → |
| HRTX | SELL | 2021-05-04 | $27K | — | Filing → |